James Chalmers to Prospective Studies
This is a "connection" page, showing publications James Chalmers has written about Prospective Studies.
Connection Strength
0.153
-
The Impact of the COVID-19 Pandemic on Exacerbations and Symptoms in Bronchiectasis: A Prospective Study. Am J Respir Crit Care Med. 2021 10 01; 204(7):857-859.
Score: 0.039
-
Pulmonary rehabilitation after exacerbation of bronchiectasis: a pilot randomized controlled trial. BMC Pulm Med. 2019 May 06; 19(1):85.
Score: 0.033
-
Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017 09; 50(3).
Score: 0.029
-
Anti-Pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis. Respir Med. 2017 07; 128:1-6.
Score: 0.029
-
A comprehensive approach to lung function in bronchiectasis. Respir Med. 2018 12; 145:120-129.
Score: 0.008
-
Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review. Respir Med. 2018 04; 137:6-13.
Score: 0.008
-
High endocan levels are associated with the need for mechanical ventilation among patients with severe sepsis. Eur Respir J. 2017 07; 50(1).
Score: 0.007